Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Statin use and risk of developing diabetes: results from the Diabetes Prevention Program.
Crandall JP, Mather K, Rajpathak SN, Goldberg RB, Watson K, Foo S, Ratner R, Barrett-Connor E, Temprosa M. Crandall JP, et al. Among authors: temprosa m. BMJ Open Diabetes Res Care. 2017 Oct 10;5(1):e000438. doi: 10.1136/bmjdrc-2017-000438. eCollection 2017. BMJ Open Diabetes Res Care. 2017. PMID: 29081977 Free PMC article.
The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S; Diabetes Prevention Program Research Group. Orchard TJ, et al. Among authors: temprosa m. Ann Intern Med. 2005 Apr 19;142(8):611-9. doi: 10.7326/0003-4819-142-8-200504190-00009. Ann Intern Med. 2005. PMID: 15838067 Free PMC article. Clinical Trial.
Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance.
Haffner S, Temprosa M, Crandall J, Fowler S, Goldberg R, Horton E, Marcovina S, Mather K, Orchard T, Ratner R, Barrett-Connor E; Diabetes Prevention Program Research Group. Haffner S, et al. Among authors: temprosa m. Diabetes. 2005 May;54(5):1566-72. doi: 10.2337/diabetes.54.5.1566. Diabetes. 2005. PMID: 15855347 Free PMC article. Clinical Trial.
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, Andres R, Saudek C, Edelstein SL, Arakaki R, Murphy MB, Shamoon H; Diabetes Prevention Program Research Group. Kitabchi AE, et al. Among authors: temprosa m. Diabetes. 2005 Aug;54(8):2404-14. doi: 10.2337/diabetes.54.8.2404. Diabetes. 2005. PMID: 16046308 Free PMC article. Clinical Trial.
Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.
Goldberg RB, Temprosa M, Haffner S, Orchard TJ, Ratner RE, Fowler SE, Mather K, Marcovina S, Saudek C, Matulik MJ, Price D; Diabetes Prevention Program Research Group. Goldberg RB, et al. Among authors: temprosa m. Diabetes Care. 2009 Apr;32(4):726-32. doi: 10.2337/dc08-0494. Epub 2009 Jan 26. Diabetes Care. 2009. PMID: 19171717 Free PMC article. Clinical Trial.
Menopause and risk of diabetes in the Diabetes Prevention Program.
Kim C, Edelstein SL, Crandall JP, Dabelea D, Kitabchi AE, Hamman RF, Montez MG, Perreault L, Foulkes MA, Barrett-Connor E; Diabetes Prevention Program Research Group. Kim C, et al. Menopause. 2011 Aug;18(8):857-68. doi: 10.1097/gme.0b013e31820f62d0. Menopause. 2011. PMID: 21709591 Free PMC article. Clinical Trial.
86 results